Outcomes in Patients With Lung Adenocarcinoma With Transformation to Small Cell Lung Cancer After EGFR Tyrosine Kinase Inhibitors Resistance: A Systematic Review and Pooled Analysis

BACKGROUND: Lung adenocarcinoma can transform into small-cell lung cancer (SCLC) when resistance to tyrosine kinase inhibitors (TKIs) develops. Approximately 3% to 10% of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) could transform to SCLC. This phenomenon has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jinhe, Xu, Lihuan, Wang, Baoshan, Kong, Wencui, Chen, Ying, Yu, Zongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867701/
https://www.ncbi.nlm.nih.gov/pubmed/35223450
http://dx.doi.org/10.3389/fonc.2021.766148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867701/
https://www.ncbi.nlm.nih.gov/pubmed/35223450
http://dx.doi.org/10.3389/fonc.2021.766148

Ejemplares similares